Shortened Course Adjuvant Radiotherapy Following TORS (NCT05714657)
A Phase II Study of Shortened Course, Dose De-Intensified Adjuvant Radiotherapy Following Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a single-arm, phase II study to establish the safety of reducing radiation dose in selected HPV-Associated OPSCC patients receiving adjuvant radiation after TORS and neck dissection. This protocol also allows for sparing of the primary resection bed, in appropriate patients, as previously published by our group and found to be safe and effective.
Who can join: Review the eligibility criteria below.
Location: Lancaster General Hospital โ Lancaster, Pennsylvania
Age range: 18 Years
๐งช Interventions in This Study
- Shortened Course Adjuvant Radiotherapy Following TORS (RADIATION)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (3 Sites)
- Lancaster General Hospital โ Lancaster, Pennsylvania
- University of Pennsylvania โ Philadelphia, Pennsylvania
- Pennsylvania Hospital โ Philadelphia, Pennsylvania
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma โ Hartford, Connecticut
- Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study โ Boston, Massachusetts
Explore by condition: All HPV-Associated Oropharyngeal Squamous Cell Carcinoma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.